Sapphire Medical Clinics and Dendrite Clinical Systems have launched the UK Medical Cannabis Registry, an initiative that is designed to rapidly expand the evidence base for medical cannabis in the UK and decrease the cost of access for patients. The launch will collect and analyse clinical information on patients taking medical cannabis treatments for all recognised eligible conditions.
“I am very pleased to report that demand for the Dendrite Web-Registry platform has reached an all-time high” Dr Peter Walton, Managing Director of Dendrite Clinical System. “We’re receiving new orders for new national and international registries every few days now – for surgical registries, medical registries, rare disease registries, medical device registries and Coronavirus Registries (for a range of Community, National, International and Global Covid-19 Registries).”
Sapphire Medical Clinics and Dendrite Clinical Systems have established the UK’s first national UK’s first comprehensive medical cannabis patient registry - UK Medical Cannabis Registry. The UK Medical Cannabis Registry will be the first of its kind covering all conditions for which there is evidence of clinical efficacy of medical cannabis. The formation of the registry means that real world evidence, cited as a key barrier to wider patient prescriptions by NHS England, will now be available on request to the medical community for analysis.
The British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS), in conjunction with Dendrite Clinical Systems, is delighted to announce the release of the First UK National Flap Registry (UKNFR) Report. The UKNFR, which was launched in August 2015, collects information on all major free and pedicled flap operations carried out in the UK.
Dendrite Clinical Systems, the publisher of Bariatric News, has announced the publication of the Bariatric News Industry and Product Guide 2019 – a comprehensive A-Z guide to companies, products and services within the bariatric and metabolic specialty. 
Dendrite Clinical Systems, the publisher of Bariatric News, is pleased to announce issue 39 of the newspaper is now available to view/download. The newspaper reports on research, technology, events and policy in the bariatric specialty, the latest clinical studies, policy changes and product news, the latest meetings and events, interviews prominent bariatric experts, and host debates between specialists on controversial topics.
Dendrite Clinical Systems and The American Vein and Lymphatic Society (formerly the American College of Phlebology) are delighted to announce the launch of the American Vein and Lymphatic Society Registry - a ‘real-time’ clinical database that will identify practice patterns for venous and lymphatic disease diagnosis and treatment across North America.
The aim of the registry is to analyse the aggregate data and produce an annual publication that will outline important demographic features, risk factors, diagnostic characteristics, disease patterns, and treatment outcomes of venous and lymphatic disease within North America.
It is hoped that the Registry will assist the AVLS in developing standards of care and guideline documents for the treatment of various venous and lymphatic disease by improving the standards of medical practitioners, the quality of patient care and patient management.
The Registry will allow physicians to enter the demographics, risk factors, clinical features, management details and follow-up of all major venous and lymphatic diseases. Outcome reports (e.g. risk-factor distribution, indications, patency rates, and complication rates) will be available in real time and physicians will have the ability to compare them with the aggregated outcomes of all entries in the database. The Registry can be programmed to generate lists for pending follow-ups, letters to patients, and reminder emails to physicians.
The Registry is web-based and allows the individual clinician to enter patient information into the database from the hospital, an office-based practice, or even from home. Clinicians can add as many cases as they wish and where possible they will be encouraged to put on retrospective data (if available).
“We are thrilled to be part of this exciting project. The registry is the largest database of its kind specifically designed for venous and lymphatic disease and will be of tremendous educational value to the AVLS, its members and ultimately, patients,” said Dr Peter Walton, Managing Director of Dendrite Clinical Systems. “The Registry represents an important milestone for the company and reflects our expanding database portfolio.”
